{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":7,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":7,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"24ababab392c","filters":{"venue":"Current Drug Targets - CNS & Neurological Disorders"}},"results":[{"id":"W2072477505","doi":"10.2174/156800705774322058","title":"CREB, Synapses and Memory Disorders: Past Progress and Future Challenges","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"CREB; Neuronal memory allocation; Neuroscience; Long-term potentiation; Aplysia; Synaptic plasticity; Transcription factor; Biology; Neuroplasticity; Cell biology; Metaplasticity; Gene; Genetics; Receptor","authors":[{"name":"Sheena A. Josselyn","is_ca":true},{"name":"Peter Nguyen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02189130959391541,"gpt":0.2922035506718325,"spread":0.2703122410779171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008266246,0.0009008654,0.00152628,0.001513274,0.0004166722,0.001095622,0.0010212,0.001918291,0.003534638],"category_scores_gemma":[0.0008570604,0.0002572855,0.0003640011,0.001652685,0.0007919457,0.002416716,0.0007791236,0.001988559,0.002105232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008653846,"about_ca_system_score_gemma":0.001257372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001199443,"about_ca_topic_score_gemma":0.002745789,"domain_scores_codex":[0.9998623,0.00003188323,0.00002034499,0.00002312445,0.00004506379,0.00001722734],"domain_scores_gemma":[0.9995155,0.0002461993,0.00003818997,0.00001616163,0.0001123055,0.0000715168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001249814,0.00008521885,0.0001900979,0.008348108,0.0000638948,0.0003308585,0.00008924082,0.0003582817,0.001215315,0.005359847,0.05247351,0.9313607],"study_design_scores_gemma":[0.0000284428,0.0001278756,0.0009030332,0.003091319,0.0000770474,0.001696668,0.0001748218,0.0001197562,0.0003194988,0.007145349,0.9862948,0.00002133368],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005707625,0.9984901,0.0000725869,0.0006986086,0.000244709,0.000001239647,0.000005513877,0.000005175887,0.0004249446],"genre_scores_gemma":[0.0004527248,0.9980277,0.0001691035,0.0003681069,0.0004026112,0.000003329678,0.00001105098,0.000001231127,0.0005641027],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003534638,"threshold_uncertainty_score":0.01182455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112341182","doi":"10.2174/1568007023338914","title":"Galanin: A Biologically Active Peptide","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Galanin; Galanin receptor; Neuropeptide; Internal medicine; Endocrinology; Biology; Central nervous system; Receptor; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08688973407603384,"gpt":0.3283329591641141,"spread":0.2414432250880802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001330705,0.0006610873,0.0003224482,0.0006454591,0.0002899451,0.001121523,0.0003523879,0.0007279526,0.003839219],"category_scores_gemma":[0.0001573951,0.00008715474,0.0002224045,0.0006368467,0.0005513235,0.0006178769,0.0007399459,0.0007432912,0.003589141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004275841,"about_ca_system_score_gemma":0.000312006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002889666,"about_ca_topic_score_gemma":0.0001294651,"domain_scores_codex":[0.9998277,0.00001966705,0.00001135648,0.00003587867,0.0000732517,0.00003204045],"domain_scores_gemma":[0.9999489,0.000004061054,0.00001056081,0.000002678225,0.00001105154,0.00002265435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009734532,0.000275956,0.002669442,0.002392261,0.00007072462,0.001810766,0.0001598169,0.0004823051,0.46408,0.007094901,0.0234565,0.4965339],"study_design_scores_gemma":[0.00007600996,0.0008170376,0.008645721,0.000313925,0.00006866031,0.006649139,0.000136406,0.000400017,0.166079,0.003385008,0.8133771,0.00005191573],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2456645,0.5508885,0.03994303,0.004654216,0.006097843,0.0006610071,0.004791512,0.003104705,0.1441947],"genre_scores_gemma":[0.7060517,0.1714509,0.01318464,0.003569358,0.001359308,0.0003035805,0.004920796,0.0002453411,0.09891436],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003839219,"threshold_uncertainty_score":0.01284349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987897200","doi":"10.2174/1568007053544183","title":"NMDA/NR2B Selective Antagonists in the Treatment of Ischemic Brain Injury","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ifenprodil; NMDA receptor; Neuroprotection; Glutamate receptor; Neuroscience; Medicine; Pharmacology; Receptor; Neurotransmission; Biology; Internal medicine","authors":[{"name":"Chen Wang","is_ca":true},{"name":"Ashfaq Shuaib","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09252142624873262,"gpt":0.4242557918291176,"spread":0.331734365580385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003092893,0.0007376521,0.001269288,0.001197095,0.0001884266,0.0003146446,0.0007885713,0.0006387791,0.003173585],"category_scores_gemma":[0.0001912773,0.0001540746,0.0003142821,0.00122605,0.0002278857,0.0004739253,0.0002400713,0.0008447301,0.002745589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003272422,"about_ca_system_score_gemma":0.000388995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006077127,"about_ca_topic_score_gemma":0.001743619,"domain_scores_codex":[0.9998951,0.00001776016,0.00001459972,0.00001610357,0.00004392672,0.00001250985],"domain_scores_gemma":[0.9999402,0.00001570901,0.00001279224,0.000002377308,0.00001944935,0.000009565214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001985533,0.000239628,0.0002000837,0.007552221,0.0000749387,0.0006603004,0.00006912037,0.0003973383,0.01382147,0.001290589,0.0163446,0.9591511],"study_design_scores_gemma":[0.0002011302,0.001034789,0.00455702,0.002265273,0.0002379204,0.007322185,0.000103854,0.0003348873,0.00779917,0.001802332,0.9743056,0.00003581864],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001488577,0.9942951,0.0003925721,0.000198408,0.0001611842,0.0000188893,0.0000310981,0.0000268144,0.00338748],"genre_scores_gemma":[0.00377785,0.9931095,0.0006447114,0.0002064064,0.0001399334,0.00001944108,0.0000657385,0.000003168006,0.002033355],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003173585,"threshold_uncertainty_score":0.01061672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056349137","doi":"10.2174/1568007043337076","title":"Exercise in a Pill: Feasibility of Energy Expenditure Targets","year":2004,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Energy, Environment, and Transportation Policies","field":"Energy","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Pill; Energy expenditure; Energy metabolism; Medicine; Pharmacology; Internal medicine","authors":[{"name":"Jean Himms‐Hagen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03501207138564143,"gpt":0.3033825570588669,"spread":0.2683704856732255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543565,0.0003691019,0.0004895647,0.0003731962,0.0001933177,0.0009092725,0.0005974399,0.0008173301,0.009517099],"category_scores_gemma":[0.0005173745,0.0001232957,0.0003732081,0.0002667351,0.0003945173,0.0008492963,0.0007288262,0.0007236849,0.001164863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001867872,"about_ca_system_score_gemma":0.0003237694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003141246,"about_ca_topic_score_gemma":0.0003850702,"domain_scores_codex":[0.9998146,0.00005909445,0.00001081195,0.00004036596,0.00004207921,0.00003312639],"domain_scores_gemma":[0.9998189,0.00007501576,0.00002035253,0.0000200451,0.00002282229,0.00004291412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006817113,0.003319654,0.003584911,0.003754488,0.0002352842,0.0004117187,0.0003076593,0.001765475,0.1159911,0.02571431,0.003132011,0.8349664],"study_design_scores_gemma":[0.003806028,0.07999819,0.08503854,0.005242208,0.001314026,0.002420204,0.002274931,0.02161201,0.1262632,0.07482868,0.5969515,0.0002505372],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6502193,0.1170768,0.08834165,0.01407617,0.002088758,0.001282293,0.0009224796,0.0006496105,0.125343],"genre_scores_gemma":[0.8761547,0.0458026,0.04525371,0.002735167,0.0009118101,0.00148174,0.0006425369,0.0001159354,0.02690178],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.009517099,"threshold_uncertainty_score":0.03183788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985778670","doi":"10.2174/156800705774322067","title":"Abeta Immunotherapy and Other Means to Remove Amyloid","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Presenilin; Genetically modified mouse; Alzheimer's disease; Amyloid precursor protein; Transgene; Amyloid (mycology); Immunotherapy; Amyloid beta; Disease; Medicine; Chemistry; Immunology; Immune system; Biochemistry; Pathology","authors":[{"name":"Edith G. McGeer","is_ca":true},{"name":"Patrick L. McGeer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05743566858691119,"gpt":0.3751797894650004,"spread":0.3177441208780892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002707831,0.0007656917,0.001321096,0.002023136,0.0003382654,0.0007115541,0.0007146751,0.001063503,0.005307667],"category_scores_gemma":[0.0002078151,0.000180692,0.00048546,0.001383292,0.0003908173,0.0008903306,0.0004236684,0.001494557,0.004579254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000369839,"about_ca_system_score_gemma":0.0004199621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000556864,"about_ca_topic_score_gemma":0.001089294,"domain_scores_codex":[0.9998851,0.00001946586,0.00001151646,0.00002212944,0.00004920463,0.00001248748],"domain_scores_gemma":[0.9999452,0.00001847308,0.000009587335,0.000004370063,0.00001407904,0.00000844302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001219477,0.0004011602,0.0001574403,0.007751312,0.00008916516,0.000630399,0.00008285198,0.0002727811,0.01235334,0.004536324,0.01520343,0.9583998],"study_design_scores_gemma":[0.00006527748,0.0003175982,0.00113792,0.001449625,0.00008343417,0.003256126,0.00006362888,0.00009343962,0.00536444,0.003682514,0.9844667,0.00001944015],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006495301,0.9945117,0.0003842748,0.0002639495,0.0002739683,0.00001686183,0.00002098092,0.00002112572,0.003857576],"genre_scores_gemma":[0.003677592,0.9898509,0.0007228793,0.0004035147,0.0002280428,0.00003031516,0.00006877018,0.000004179522,0.005013868],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005307667,"threshold_uncertainty_score":0.01775593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065097064","doi":"10.2174/1568007033338832","title":"Osteoporosis in Anorexia Nervosa: A Brittle Future","year":2003,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Anorexia nervosa; Osteopenia; Osteoporosis; Medicine; Anorexia; Pediatrics; Endocrinology; Internal medicine; Eating disorders; Psychiatry; Bone mineral","authors":[{"name":"Debra K. Katzman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04091482381570872,"gpt":0.3522683560232328,"spread":0.3113535322075241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006264067,0.0006010004,0.001233324,0.001458416,0.0004781126,0.001058287,0.0005772078,0.002200071,0.002388379],"category_scores_gemma":[0.0006848325,0.0002667664,0.0003458055,0.001580084,0.001098857,0.001749872,0.0006099973,0.002209368,0.001269933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008203392,"about_ca_system_score_gemma":0.001884905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002509746,"about_ca_topic_score_gemma":0.006757188,"domain_scores_codex":[0.9997624,0.00006480411,0.00003570011,0.00002649839,0.00009233424,0.00001817638],"domain_scores_gemma":[0.9996527,0.0001650722,0.00004923182,0.00001128954,0.00008401092,0.00003760728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006578529,0.00008256015,0.0006007972,0.008685118,0.00005598977,0.0006500762,0.0001993826,0.0001962571,0.0005382256,0.004526381,0.0307788,0.9536208],"study_design_scores_gemma":[0.00004137097,0.0002382511,0.005647399,0.01207673,0.000109164,0.01115124,0.0007177414,0.0001516207,0.0002043176,0.008981981,0.9606445,0.00003559489],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000102345,0.9978589,0.00005346066,0.001020526,0.0001859524,0.000002011906,0.000003125387,0.000003427175,0.0007701881],"genre_scores_gemma":[0.0008392544,0.997647,0.0001192948,0.0005273828,0.0002850476,0.000003651862,0.000004747697,6.87226e-7,0.00057289],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002509746,"threshold_uncertainty_score":0.007989943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005425566","doi":"10.2174/156800705774322085","title":"Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Pathogenesis; Disease; Apolipoprotein E; Alzheimer's disease; Medicine; Cholesterol; Apolipoprotein B; Bioinformatics; Immunology; Internal medicine; Biology","authors":[{"name":"Daniela Fenili","is_ca":false},{"name":"JoAnne McLaurin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0708535222575065,"gpt":0.3655597761296528,"spread":0.2947062538721463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761337,0.0008386021,0.001621927,0.001552769,0.0003879829,0.0009736361,0.0007857269,0.001910743,0.004514659],"category_scores_gemma":[0.0004859302,0.000249281,0.000455309,0.001348561,0.0004773294,0.001569062,0.0005619496,0.002157408,0.004151541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006642073,"about_ca_system_score_gemma":0.0009953371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008851447,"about_ca_topic_score_gemma":0.001978617,"domain_scores_codex":[0.9997979,0.00004419042,0.00002294196,0.00002709708,0.00008625833,0.00002172068],"domain_scores_gemma":[0.999775,0.00008490952,0.00002697159,0.00001009537,0.00006930285,0.00003386162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001273167,0.0001654653,0.0001778926,0.006598413,0.0000794727,0.000503823,0.00006646483,0.0003268977,0.003488981,0.006547105,0.04840029,0.9335178],"study_design_scores_gemma":[0.00004965953,0.0001480223,0.0006321499,0.00243976,0.00006627547,0.001404655,0.00006913546,0.00008636256,0.0005972682,0.003812598,0.9906788,0.00001530655],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001489926,0.9971489,0.0001588288,0.0007571316,0.0002956416,0.000004578183,0.000009710053,0.000009837,0.001466322],"genre_scores_gemma":[0.0007858743,0.9964561,0.0003489122,0.0004943905,0.0002436225,0.000008266927,0.00002180111,0.000001647445,0.001639265],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004514659,"threshold_uncertainty_score":0.01510304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}